STOCK TITAN

[144] Ginkgo Bioworks Holdings, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Ginkgo Bioworks (DNA) Form 144 notice: An insider notified the sale of 10,000 Class A shares through Fidelity Brokerage Services (900 Salem St, Smithfield RI) with an approximate aggregate market value of $109,209.3447,089,598 and an approximate sale date of 09/08/2025. All 10,000 shares were acquired from the issuer as restricted stock vesting on dates between 11/19/2021 and 03/11/2022 and were paid as compensation. The filer reports no securities sold in the past three months.

Avviso Form 144 di Ginkgo Bioworks (DNA): Un insider ha comunicato la vendita di 10.000 azioni di Classe A tramite Fidelity Brokerage Services (900 Salem St, Smithfield RI) con un valore di mercato aggregato approssimativo di $109.209,34. Il deposito indica le azioni Classe A in circolazione pari a 47.089.598 e una data di vendita approssimativa del 08/09/2025. Tutte le 10.000 azioni sono state acquisite dall’emittente come azioni vincolate in scadenza (restricted stock vesting) in date comprese tra il 19/11/2021 e l’11/03/2022 e sono state corrisposte come compenso. Il dichiarante segnala di non aver venduto titoli negli ultimi tre mesi.

Aviso Form 144 de Ginkgo Bioworks (DNA): Un insider notificó la venta de 10.000 acciones Clase A a través de Fidelity Brokerage Services (900 Salem St, Smithfield RI) con un valor de mercado agregado aproximado de $109.209,34. La presentación indica que las acciones Clase A en circulación son 47.089.598 y una fecha aproximada de venta del 08/09/2025. Las 10.000 acciones fueron adquiridas del emisor como restricted stock vesting (acciones restringidas en malla) en fechas entre el 19/11/2021 y el 11/03/2022 y se pagaron como compensación. El declarante informa que no vendió valores en los últimos tres meses.

Ginkgo Bioworks (DNA) Form 144 고지: 내부자가 Fidelity Brokerage Services(900 Salem St, Smithfield RI)를 통해 Class A 주식 10,000주의 매각을 통지했으며, 대략적인 총 시가 약 $109,209.34로 기재되어 있습니다. 제출서류에는 회사의 유통 중인 Class A 주식 수를 47,089,598주로 기재했고, 예상 매각일은 2025-09-08로 표시되어 있습니다. 해당 10,000주는 모두 발행사로부터 restricted stock vesting(제한조건부 주식의 확정) 형태로 2021-11-19부터 2022-03-11 사이에 취득되었으며 보수로 지급되었습니다. 신고인은 지난 3개월 동안 판매한 증권이 없음을 보고했습니다.

Avis Form 144 de Ginkgo Bioworks (DNA) : Un initié a notifié la vente de 10 000 actions de catégorie A via Fidelity Brokerage Services (900 Salem St, Smithfield RI) pour une valeur de marché totale approximative de 109 209,34 $. Le dossier indique que le nombre d’actions de catégorie A en circulation est de 47 089 598 et une date de vente approximative le 08/09/2025. Les 10 000 actions ont été acquises auprès de l’émetteur en tant que restricted stock vesting aux dates comprises entre le 19/11/2021 et le 11/03/2022 et ont été versées en rémunération. Le déclarant signale n’avoir vendu aucun titre au cours des trois derniers mois.

Ginkgo Bioworks (DNA) Form 144-Mitteilung: Ein Insider meldete den Verkauf von 10.000 Class-A-Aktien über Fidelity Brokerage Services (900 Salem St, Smithfield RI) mit einem ungefähren Gesamtmarktwert von $109.209,34. Die Einreichung nennt die ausstehenden Class-A-Aktien mit 47.089.598 und ein ungefähres Verkaufsdatum 08.09.2025. Alle 10.000 Aktien wurden vom Emittenten als restricted stock vesting an Daten zwischen dem 19.11.2021 und dem 11.03.2022 erworben und als Vergütung ausgegeben. Der Meldende gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider plans to sell 10,000 vested Class A shares (~$109k) into the market via Fidelity on 09/08/2025.

The filing is a routine Rule 144 disclosure showing that the shares were acquired through restricted stock vesting and paid as compensation between 2021 and 2022. The total shares to be sold equal the sum of the vesting lots, indicating a disposal of previously restricted holdings rather than newly acquired shares. No prior sales by the filer in the past three months are reported, and the filing contains no material non-public disclosures.

TL;DR: This is a standard insider sale notice with acquisition history disclosed; procedural compliance appears met.

The Form 144 documents the broker, share count, market value, acquisition dates, and that payment was for compensation. It includes the required representation about material non-public information. The filing does not disclose any unusual terms or related-party transfers; it appears to be a routine disclosure under Rule 144.

Avviso Form 144 di Ginkgo Bioworks (DNA): Un insider ha comunicato la vendita di 10.000 azioni di Classe A tramite Fidelity Brokerage Services (900 Salem St, Smithfield RI) con un valore di mercato aggregato approssimativo di $109.209,34. Il deposito indica le azioni Classe A in circolazione pari a 47.089.598 e una data di vendita approssimativa del 08/09/2025. Tutte le 10.000 azioni sono state acquisite dall’emittente come azioni vincolate in scadenza (restricted stock vesting) in date comprese tra il 19/11/2021 e l’11/03/2022 e sono state corrisposte come compenso. Il dichiarante segnala di non aver venduto titoli negli ultimi tre mesi.

Aviso Form 144 de Ginkgo Bioworks (DNA): Un insider notificó la venta de 10.000 acciones Clase A a través de Fidelity Brokerage Services (900 Salem St, Smithfield RI) con un valor de mercado agregado aproximado de $109.209,34. La presentación indica que las acciones Clase A en circulación son 47.089.598 y una fecha aproximada de venta del 08/09/2025. Las 10.000 acciones fueron adquiridas del emisor como restricted stock vesting (acciones restringidas en malla) en fechas entre el 19/11/2021 y el 11/03/2022 y se pagaron como compensación. El declarante informa que no vendió valores en los últimos tres meses.

Ginkgo Bioworks (DNA) Form 144 고지: 내부자가 Fidelity Brokerage Services(900 Salem St, Smithfield RI)를 통해 Class A 주식 10,000주의 매각을 통지했으며, 대략적인 총 시가 약 $109,209.34로 기재되어 있습니다. 제출서류에는 회사의 유통 중인 Class A 주식 수를 47,089,598주로 기재했고, 예상 매각일은 2025-09-08로 표시되어 있습니다. 해당 10,000주는 모두 발행사로부터 restricted stock vesting(제한조건부 주식의 확정) 형태로 2021-11-19부터 2022-03-11 사이에 취득되었으며 보수로 지급되었습니다. 신고인은 지난 3개월 동안 판매한 증권이 없음을 보고했습니다.

Avis Form 144 de Ginkgo Bioworks (DNA) : Un initié a notifié la vente de 10 000 actions de catégorie A via Fidelity Brokerage Services (900 Salem St, Smithfield RI) pour une valeur de marché totale approximative de 109 209,34 $. Le dossier indique que le nombre d’actions de catégorie A en circulation est de 47 089 598 et une date de vente approximative le 08/09/2025. Les 10 000 actions ont été acquises auprès de l’émetteur en tant que restricted stock vesting aux dates comprises entre le 19/11/2021 et le 11/03/2022 et ont été versées en rémunération. Le déclarant signale n’avoir vendu aucun titre au cours des trois derniers mois.

Ginkgo Bioworks (DNA) Form 144-Mitteilung: Ein Insider meldete den Verkauf von 10.000 Class-A-Aktien über Fidelity Brokerage Services (900 Salem St, Smithfield RI) mit einem ungefähren Gesamtmarktwert von $109.209,34. Die Einreichung nennt die ausstehenden Class-A-Aktien mit 47.089.598 und ein ungefähres Verkaufsdatum 08.09.2025. Alle 10.000 Aktien wurden vom Emittenten als restricted stock vesting an Daten zwischen dem 19.11.2021 und dem 11.03.2022 erworben und als Vergütung ausgegeben. Der Meldende gibt an, in den letzten drei Monaten keine Wertpapiere verkauft zu haben.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Ginkgo Bioworks Holdings Inc

NYSE:DNA

DNA Rankings

DNA Latest News

DNA Latest SEC Filings

DNA Stock Data

609.17M
55.40M
6.77%
79.18%
13.94%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
BOSTON